Market Closed -
Nyse
01:30:02 16/05/2024 am IST
5-day change
1st Jan Change
159.8
USD
+0.73%
-2.24%
-21.47%
This article is reserved for members
Not a member ?
Free registration
Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM
15/05
Top Premarket Decliners
08/05
MT
Transcript : Inspire Medical Systems, Inc., Q1 2024 Earnings Call, May 07, 2024
08/05
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Posts Q1 Revenue $164M, vs. Street Est of $161.1M
08/05
MT
Inspire Medical Systems Q1 Loss Narrows, Revenue Rises; Full-Year Revenue Outlook Raised -- Shares Slump After Hours
08/05
MT
Inspire Medical Systems, Inc. Revises Financial Guidance for the Full Year 2024
08/05
CI
Inspire Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
08/05
CI
RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target
19/04
MT
Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing
19/04
MT
Wall St set for higher open on megacaps boost; earnings, Fed comments on tap
17/04
RE
Inspire Medical Systems Insider Sold Shares Worth $8,203,581, According to a Recent SEC Filing
04/04
MT
Morgan Stanley Initiates Inspire Medical Systems at Overweight Rating With $250 Price Target
19/03
MT
Transcript : Inspire Medical Systems, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 10:30 AM
19/03
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating
07/02
MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating
07/02
MT
Inspire Medical Systems Q4 Net Income, Revenue Rise; Reaffirms 2024 Revenue Outlook
07/02
MT
Transcript : Inspire Medical Systems, Inc., Q4 2023 Earnings Call, Feb 06, 2024
07/02
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q4 Revenue $192.5M, vs. Street Est of $191.2M
07/02
MT
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
07/02
CI
Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024
07/02
CI
Inspire Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
07/02
CI
Inspire Medical Systems Names CEO Timothy P. Herbert as Board Chair
05/02
MT
Inspire Medical Systems, Inc. Announces Board Retirements
05/02
CI
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024
26/01
CI
Jefferies Initiates Inspire Medical Systems With Buy Rating, Price Target is $245
19/01
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patientâs breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
More about the company
Last Close Price
159.8
USD
Average target price
250.7
USD
Spread / Average Target
+56.95%
Consensus
1st Jan change
Capi.
-21.47% 4.75B +10.86% 126B -5.84% 11.27B +4.17% 9.12B +40.13% 5.61B +8.77% 3.45B -6.03% 2.89B -12.05% 2.07B -7.83% 2.05B -22.84% 1.8B
Medical Devices & Implants
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**